% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • belco_mc belco_mc Aug 16, 2012 6:51 AM Flag

    SRPT filed a Notice of Effectiveness

    I have been holding a reduced position in SRPT because of a fear of a secondary.

    The stock is up 20% in that time.

    If the company would do a secondary, I guess it would be at a 10% discount to market, or less, given the new investors who are now beginning to understand the real story here.

    If you are focusing on a secondary as a negative, you are missing the real important catalysts that are on the horizon that can move the stock much, much higher still.

    I have made that mistake and I'm guessing others have as well.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You may be correct, but this is a strange thread. The original post asks for clarification on the notice of effectiveness, and the reply and subsequent discussion (other than my posts and yours) is about the effectiveness of SRPT's technology and drug candidates. That is undeniably peculiar.

      I sold a few shares yesterday (not at the top, but close enough), and I will continue to look for opportunities to lighten up a bit. I could buy those shares back today and pocket a small profit, but I probably won't. I still own enough for the time being.

20.93-0.26(-1.23%)May 31 4:00 PMEDT